278 related articles for article (PubMed ID: 32658845)
1. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
Yang AP; Liu JP; Tao WQ; Li HM
Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
5. The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.
Liu G; Zhang S; Hu H; Liu T; Huang J
Scott Med J; 2020 Nov; 65(4):154-160. PubMed ID: 32865157
[TBL] [Abstract][Full Text] [Related]
6. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
7. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
[TBL] [Abstract][Full Text] [Related]
8. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
[TBL] [Abstract][Full Text] [Related]
9. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
Kong M; Zhang H; Cao X; Mao X; Lu Z
Epidemiol Infect; 2020 Jul; 148():e139. PubMed ID: 32641174
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.
Sun S; Cai X; Wang H; He G; Lin Y; Lu B; Chen C; Pan Y; Hu X
Clin Chim Acta; 2020 Aug; 507():174-180. PubMed ID: 32339487
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
Liu Y; Du X; Chen J; Jin Y; Peng L; Wang HHX; Luo M; Chen L; Zhao Y
J Infect; 2020 Jul; 81(1):e6-e12. PubMed ID: 32283162
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
[No Abstract] [Full Text] [Related]
14. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
16. High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients.
Pimentel GD; Dela Vega MCM; Laviano A
Clin Nutr ESPEN; 2020 Dec; 40():101-102. PubMed ID: 33183520
[TBL] [Abstract][Full Text] [Related]
17. Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19.
Zahorec R; Hulin I; Zahorec P
Bratisl Lek Listy; 2020; 121(7):466-470. PubMed ID: 32989997
[TBL] [Abstract][Full Text] [Related]
18. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
Peng Y; Meng K; He M; Zhu R; Guan H; Ke Z; Leng L; Wang X; Liu B; Hu C; Ji Q; Keerman M; Cheng L; Wu T; Huang K; Zeng Q
J Am Heart Assoc; 2020 Oct; 9(19):e016796. PubMed ID: 32794415
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.
Zhu C; Yu S; Zhao H; Shen H; Yang J; Zhao L; Wu W
Clin Chem Lab Med; 2020 Aug; 58(9):e167-e170. PubMed ID: 32609644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
